Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

it has been barred by an old federal law from paying for weight-loss drugs. But last November Biden proposed new rules to allow Medicare and Medicaid to pay for these meds. The change would not ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

The latest glucagon-like peptide 1 (GLP-1) receptor agonists have been heralded for their potential to not only boost weight loss and glucose ... tirzepatide, and new GLP-1 drugs in the research ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

A new study published in the Nature Medicine monthly journal highlights the benefits and risks of weight-loss drugs like Ozempic and Wegovy. Positives include reduced risks of infections and ...

Diabetes and weight loss drugs Ozempic ... the price of certain drugs with the companies that make them — was instituted following the Inflation Reduction Act of 2022, which President Joe ...